4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 81 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $29,000 | -99.5% | 3,573 | -99.6% | 0.01% | -99.5% |
| Q2 2022 | $6,014,000 | -77.3% | 861,607 | -50.9% | 2.05% | -47.4% |
| Q1 2022 | $26,543,000 | -19.9% | 1,755,506 | +16.3% | 3.90% | +3.8% |
| Q4 2021 | $33,128,000 | +11.7% | 1,509,944 | +37.3% | 3.76% | -30.3% |
| Q3 2021 | $29,665,000 | +30.3% | 1,099,944 | +16.3% | 5.39% | -8.9% |
| Q2 2021 | $22,765,000 | +74.4% | 945,382 | +214.2% | 5.92% | +150.7% |
| Q1 2021 | $13,052,000 | +1474.4% | 300,886 | +1404.4% | 2.36% | +1271.5% |
| Q4 2020 | $829,000 | – | 20,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,007,413 | $89,004,643 | 3.76% |
| Opaleye Management Inc. | 330,000 | $7,329,300 | 2.55% |
| Deep Track Capital, LP | 2,656,901 | $59,009,771 | 2.48% |
| Eagle Health Investments LP | 437,911 | $9,726,003 | 2.24% |
| COMMODORE CAPITAL LP | 598,385 | $13,290 | 2.00% |
| Octagon Capital Advisors LP | 499,996 | $11,104,911 | 1.73% |
| Casdin Capital, LLC | 630,000 | $13,992,300 | 1.08% |
| Soleus Capital Management, L.P. | 254,700 | $5,656,887 | 0.81% |
| VIKING GLOBAL INVESTORS LP | 3,937,914 | $87,461,070 | 0.44% |
| Peloton Wealth Strategists | 37,000 | $822 | 0.40% |